Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer

2 Pogledi
administrator
administrator
09/30/23

Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.

  • Kategorija

Prikaži više

0 Komentari Poredaj po

Nema komentara

Komentari na Facebooku

Sljedeći